In TH-MYCN transgenic mice, the administration of β-blockers transiently reduced tumor growth; more importantly, β-blockers used in combination with vincristine, were able to increase the antitumor effect of vincristine compared with this chemotherapeutic agent alone. Here, MYCN is linked to neoplasm.